atrasentan has been researched along with ramipril in 2 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (ramipril) | Trials (ramipril) | Recent Studies (post-2010) (ramipril) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 2,151 | 606 | 509 |
| Protein | Taxonomy | atrasentan (IC50) | ramipril (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.004 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.253 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, F; Kirchengast, M; Pang, X; Stessel, H; Wölkart, G | 1 |
| Benito, B; Bermejo, S; Dominguez-Báez, P; Jacobs-Cacha, C; Llorens-Cebria, C; Martinez-Diaz, I; Martos, N; Ortiz, A; Pieper, MP; Soler, MJ; Van den Bosch, MM; Vergara, A | 1 |
2 other study(ies) available for atrasentan and ramipril
| Article | Year |
|---|---|
Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrasentan; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Female; Fibrosis; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Oxidative Stress; Pyrrolidines; Ramipril; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left; Ventricular Pressure | 2007 |
Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice.
Topics: Animals; Atrasentan; Blood Glucose; Diabetes Mellitus, Type 2; Endothelin Receptor Antagonists; Mice; Ramipril; Receptors, Endothelin; Renin-Angiotensin System; Sodium-Glucose Transporter 2 | 2022 |